Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
VRCA | Verrica Pharmaceuticals Inc. | Common stock, $0.0001 par value per share | 9.99% | $9.36M | 15.9M | Caligan Partners LP | Dec 31, 2024 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|